Hemochromatosis is a disease of iron export dysregulation linked in most cases to the recently cloned hemochromatosis gene (HFE). Of particular interest is the transport of iron from the enterocyte and macrophage, which is excessive when HFE is defective. This competing renewal application seeks to test the hypothesis that the humoral signal reflecting both iron stores and erythropoiesis is the soluble transferrin receptor (sTfR). It is proposed that cellular reception involves HFE and that signal transduction is mediated through the membrane transferrin receptor (mTfR).
Three specific aims are proposed:
Aim 1 : using an animal model of hemochromatosis in which the b2 microglobulin gene has been knocked out, small intestinal and bone marrow transplantation studies between (b2m -/-) and wt C57BL/6 mice will be carried out to evaluate whether cellular iron egress is disregulated due to defective cellular receptors or a defective humoral signal.
Aim 2 proposes to establish an in vitro model of regulated iron egress to better study the mechanism by which HFE initiates alterations in cellular iron egress. Existing EBV transformed cells from homozygous hemochromatosis patients will be used. These cells transport iron twice as fast as control cells; the effects of transfection with HFE on this transport rate, as well as co-precipitation experiments with antibodies to HFE, will be used to evaluate their hypothesis and to directly test the sTfR as a signal molecule.
In Aim 3, other forms of iron overload will be evaluated, such as porphyria cutanea tarda and African iron overload, and will be examined using EBV transformed cells and transfection of wt HFE.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK020630-22
Application #
6380407
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
1979-07-01
Project End
2003-06-30
Budget Start
2001-07-01
Budget End
2003-06-30
Support Year
22
Fiscal Year
2001
Total Cost
$320,094
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Toomajian, Christopher; Ajioka, Richard S; Jorde, Lynn B et al. (2003) A method for detecting recent selection in the human genome from allele age estimates. Genetics 165:287-97
Ajioka, Richard S; Levy, Joanne E; Andrews, Nancy C et al. (2002) Regulation of iron absorption in Hfe mutant mice. Blood 100:1465-9
Bulaj, Z J; Franklin, M R; Phillips, J D et al. (2000) Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda. J Lab Clin Med 136:482-8
Bulaj, Z J; Ajioka, R S; Phillips, J D et al. (2000) Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 343:1529-35
Lonjou, C; Collins, A; Ajioka, R S et al. (1998) Allelic association under map error and recombinational heterogeneity: a tale of two sites. Proc Natl Acad Sci U S A 95:11366-70
Bernard, P S; Ajioka, R S; Kushner, J P et al. (1998) Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescent hybridization probes. Am J Pathol 153:1055-61
Edwards, C Q; Griffen, L M; Ajioka, R S et al. (1998) Screening for hemochromatosis: phenotype versus genotype. Semin Hematol 35:72-6
Ajioka, R S; Jorde, L B; Gruen, J R et al. (1997) Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 60:1439-47
Ajioka, R S; Yu, P; Gruen, J R et al. (1997) Recombinations defining centromeric and telomeric borders for the hereditary haemochromatosis locus. J Med Genet 34:28-33
Bulaj, Z J; Griffen, L M; Jorde, L B et al. (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799-805

Showing the most recent 10 out of 18 publications